Gibson MK, Keane FK. Neoadjuvant and adjuvant therapy for locally advanced resectable thoracic esophageal cancer. Updated. 2025. Accessed at https://www.uptodate.com/contents/neoadjuvant-and-adjuvant-therapy-for-locally-advanced-resectable-thoracic-esophageal-cancer on June 10, 2025.
Heron DE, Gibson MK. Treatment of locally advanced inoperable or unresectable cancer of the oesophagus. Updated. 2025. Accessed at https://www.uptodate.com/contents/management-of-locally-advanced-unresectable-or-inoperable-esophageal-cancer on June 10, 2025.
Ku GY, Ilson DH. Chapter 71: Cancer of the esophagus. In: Niederhuber JE, Armitage JO, Doroshow JH, Kastan MB, Tepper JE, editors. Abeloff’s Clinical Oncology. 6th ed. Philadelphia, Pa. Elsevier: 2020.
National Cancer Institute. Esophageal Cancer Treatment (PDQ®) – Health professional version. 2025. Accessed at https://www.cancer.gov/types/esophageal/hp/esophageal-treatment-pdq on June 6, 2025.
National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology: Esophageal and Esophagogastric Junction Cancers. V.3.2025. Accessed at www.nccn.org on June 6, 2025.
Yoon HH. Second- and later-line systemic therapy for metastatic gastric and esophageal cancer. Updated. 2025. Accessed at https://www.uptodate.com/contents/second-and-later-line-systemic-therapy-for-metastatic-gastric-and-esophageal-cancer on June 6, 2025.
Yoon HH, Strickland MR. Initial systemic therapy for metastatic esophageal and gastric cancer. Updated. 2025. Accessed at https://www.uptodate.com/contents/initial-systemic-therapy-for-metastatic-esophageal-and-gastric-cancer on June 6, 2025.
